Introduction. Case Report



Similar documents
ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

بسم هللا الرحمن الرحيم

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

A Case of Advanced Malignant Pleural Mesothelioma Treatment with Chemotherapy and Photodynamic Therapy

Mesothelioma: Questions and Answers

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

Case of the. Month October, 2012

Case Report Pleural Mesothelioma Presenting as Periumbilical Metastasis: The First Clinical Documentation

Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge

J of Evidence Based Med & Hlthcare, pissn , eissn / Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

Malignant Mesothelioma

Malignant Mesothelioma

What is Mesothelioma?

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Sternotomy and removal of the tumor

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Primary -Benign - Malignant Secondary

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines

Malignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson

Summary of treatment benefits

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Malignant Pleural Mesothelioma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Understanding Pleural Mesothelioma

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Neoplasms of the LUNG and PLEURA

Cardiac Masses and Tumors

Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis

Rare Thoracic Tumours

Small Cell Lung Cancer

Lung Cancer: Diagnosis, Staging and Treatment

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Basic Data. 鍾 XX, female Age:59 y/o

A succesfull case of HIPEC in a peritoneal mesothelioma patient

General Information About Non-Small Cell Lung Cancer

Omental mesothelioma as a diagnostic and therapeutic challenge: A case report

Mesothelioma. Malignant Pleural Mesothelioma

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Diagnostic Challenge. Department of Pathology,

Screening, early referral and treatment for asbestos related cancer

Tina Mosaferi, Harvard Medical School Year III Gillian Lieberman, MD

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Asbestos Related Diseases

Small cell lung cancer

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma

Exploring the Role of Vitamins in Achieving a Healthy Heart

Recommendations for the Reporting of Pleural Mesothelioma

Diagnosis of Mesothelioma Pitfalls and Practical Information

Update on Mesothelioma

PET/CT in Lung Cancer

International Journal of Case Reports in Medicine

A 53-year-old woman presented in September 1991 to Adiyaman State Hospital with pain on the left side of the chest, dyspnoea, and dry cough.

Case Report Primary Pericardial Mesothelioma: A Rare Entity

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08

Case Report: Whole-body Oncologic Imaging with syngo TimCT

Malignant pleural mesothelioma P/D vs. EPP

Malignant Pleural Mesothelioma in Singapore

HEALTH CARE FOR EXPOSURE TO ASBESTOS The SafetyNet Centre for Occupational Health and Safety Research Memorial University

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Malignant Mesothelioma

The develpemental origin of mesothelium

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

How To Understand How Cancer Works

Male. Female. Death rates from lung cancer in USA

PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S.

Recommendations for cross-sectional imaging in cancer management, Second edition

Notice of Faculty Disclosure

MALIGNANT PLEURAL MESOTHELIOMA TREATED IN CLINIC FOR PULMONARY DISEASES AND TUBERCULOSIS PODHRASTOVI IN TEN-YEAR PERIOD ( FROM 1998 TO 2007 )

Asbestos and your lungs

B10/S/a Cancer: Malignant Mesothelioma (Adult)

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

INFLAMMATORY PLEURAL EFFUSION

Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW

OBJECTIVES By the end of this segment, the community participant will be able to:

Malignant Mesothelioma

Plueral Malignancy: Radiologic-pathologic

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

The Proposed New International TNM Staging System for Malignant Pleural Mesothelioma: Application to Imaging

MESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC

3T MRI in evaluation of asbestos-related thoracic diseases preliminary results

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

Radiologic Diagnosis of Spinal Metastases

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

Lung Cancer and Mesothelioma

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.

Pictorial Review of Tuberculosis involving the Pleura.

Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope

How To Treat Lung Cancer At Cleveland Clinic

A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma

Transcription:

DOI: 10.4046/trd.2009.67.4.369 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2009;67:369-373 CopyrightC2009. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. Image of the Month Malignant Mesothelioma Presenting as Large Neck Mass Departments of 1 Radiology, 2 Pulmonology, 3 Pathology, The Catholic University of Korea College of Medicine, Seoul, Korea Bae Young Lee, M.D. 1, Hyeon Sook Kim, M.D. 1, Kyung Sup Song, M.D. 1, Song Mee Cho, M.D. 1, Kang Hoon Lee, M.D. 1, Jung Eun Choi, M.D. 1, Sang Haak Lee, M.D. 2, Hwa Sik Moon, M.D. 2, Ji Young Kang, M.D. 2, Hyun Hee Kang, M.D. 2, Ki Ouk Min, M.D. 3 Malignant mesothelioma is the most common primary malignant tumor involving pleura, but its diagnosis is difficult to determine by pathology in addition to the fact that it is rare. We present an unusual case of malignant mesothelioma, which initially presented as large neck mass contrary to the more common presentation of a rind like growth along the pleura demonstrated on imaging and by pathologic findings. Key Words: Mesothelioma, Neck, Pleura Introduction Malignant mesothelioma is a rare and aggressive malignant tumor that arises from the pleura or, rarely, peritoneal and pericardial cavities, and the tunica vaginalis testis. Its incidence is increasing due to long latency period from asbestos exposure and widespread use of asbestos before strong relationship of malignant mesothelioma with asbestos was documented. Immunohistochemical staining technique becomes important to confirm diagnosis 1-3. We present unusual malignant mesothelioma presenting as large neck mass. Case Report A 61-year-old male admitted for the evaluation of right shoulder pain for several months and acute swelling of right lower neck for last 1 week. He had diabetes mellitus and no history of asbestos exposure. On physical exam, there was diffuse swelling in right lower Address for correspondence: Hyeon Sook Kim, M.D. Department of Radiology, St. Paul's Hospital, The Catholic University of Korea College of Medicine, 620-56, Jeonnongdong, Dongdaemoon-gu, Seoul 130-709, Korea Phone: 82-2-958-2085, Fax: 82-2-960-4568 E-mail: hskimsph@catholic.ac.kr Received: Aug. 21, 2009 Accepted: Sep. 18, 2009 neck as compared with left side and decreased breathing sound of right lung field. Patient did not complain chest pain or dyspnea. Laboratory findings were within normal range except elevated glucose level. Chest roentgenogram (Figure 1A) showed large soft tissue mass in right lower neck and apical portion of right hemithorax with minimal pleural reaction at costophrenic sulcus. Non-ECG gated 16-row multi-detector computed tomography (MDCT, Light Speed 16; GE, Milwaukee, WI, USA) of chest was performed with 1.25 mm slice thickness. MDCT showed large muscle density mass in right lower neck, connected with apical portion of right hemithorax beyond rib cage, and this mass showed poor contrast enhancement (<HU 10) (Figure 1B). Magnetic resonance imaging (MRI, SIGNA HDx; GE) was performed, and this mass showed homogenous iso-signal intensity (SI) on T1 weighted image and homogenous high SI on T2 weighted image with well defined border compared to the signal of adjacent muscles. This mass showed homogeneous enhancement after contrast infusion (Figure 1C-E). There was no definite evidence of necrosis or hemorrhage within the mass on CT and MR images. Integrated computed tomography-positron emission tomography (CT-PET, Biograph LSO; Siemens, Knoxville, TN, USA) was done and intense uptakes of this large mass and scattered small pleural plaques were revealed (Figure 1F). There was 369

BY Lee et al: Malignant mesothelioma of neck Figure 1. Images of malignant mesothelioma. Chest radiography (A) shows large soft tissue mass ( ) in right lower neck and right apex and small pleural effusion (arrow) in right costophrenic sulcus. There is no definite displacement or destruction of rib and contracture of right hemithorax. Contrast enhanced coronal CT image (B) reveals large muscle density malignant mesothelioma ( ) in right lower neck and right apex through rib cages. Mild pleural thickening (arrow head) and small pleural effusion (arrow) are also seen. The mass ( ) shows iso-signal intensity on T1 weighted axial MR image (C) and high signal intensity on T2 weighted image (D) with good contrast enhancement on coronal T1 weighted image (E). Soft tissue contrast between tumor and adjacent soft tissue is superior in MR than CT. Coronal PET image (F) reveals the intense uptake (SUV=9.6) of large malignant mass ( ) and small pleural nodules (arrow heads). SUV: standardized uptake valve. no displacement or destruction of ribs. Closed pleural biopsy and thoracentesis were done, and poorly differentiated adenocarcinoma was revealed. Open surgical biopsy of neck mass was performed, and poorly differentiated adenocarcinoma was revealed on hematoxylin-eosin (H&E) stain (Figure 2A). Special immunohistochemical stains using calretinin and cytokeratin 5/6 confirmed the epithelial type of malignant mesothelioma (Figure 2B, C). Patient has received chemotherapy using pemetrexed-cisplatin (9 cycles) and gemcitabine-carboplastin (2 cycles) and been tolerable state for 17 months after di- 370 agnosis, and he is still alive with relatively good general status and regression of neck mass (Figure 3). Discussion Malignant mesothelioma is originated from the mesothelial tissues of the pleura, peritoneum, pericardium, and tunica vaginalis testis. Most tumors are originated from pleura ( 90%) and followed by the peritoneum (6 10%)1-3. About 2,000 3,000 new cases are reported in the United States every year4. Approximately 80% of malignant mesothelioma is associated with prior as-

Tuberculosis and Respiratory Diseases Vol. 67. No. 4, Oct. 2009 Figure 2. Histology of malignant mesothelioma. The tumor is composed of diffuse asheets of round to polygonal cells (H&E stain, 200) (A). Immunohistochemical stains by CK 5/6 (B) and calretinin (C) show strong and diffuse cytoplasmic immunoreactivity in the tumor cells. Figure 3. Follow up chest radiograph after 19 months shows regression of large neck mass and bilateral pleural effusions (arrows). bestos exposure. Mean age at diagnosis is 60 years because of long latent period between occupational asbestos exposure and tumor development and the ratio of male to female is 5 11-3,5. A review about mesothelioma revealed that 99% had a latent period of more than 15 years and 96% had at least 20 years latent period. 1 Median latent period was 32 years. Frequent symptoms are dyspnea, chest pain, cough, fatigue, and weight loss. Common physical findings are dullness to percussion and decreased breathing sound. Marked unilateral contraction of affected side of hemithorax may be possible in advanced case. Laboratory findings are usually nonspecific3. Patient in this case does not complaint dyspnea and chest pain and complaint neck mass and shoulder pain. Breathing sound is decreased in right hemithorax. Common abnormal findings of chest radiograph are 371

BY Lee et al: Malignant mesothelioma of neck pleural effusion, pleural plaque, and pleural thickening. Diffuse pleural thickening is most common finding 3. CT is the primary modality for tumor staging. Common CT findings are pleural thickening, interlobular fissure thickening, pleural effusion, pleural calcification, and chest wall invasion 5,6. Pleural thickening is also most common feature on CT 6. Tumor growth leads to rindlike encasement of the lung, and contraction of the affected hemithorax is also common. In chest wall involvement, frequent manifestations are obliteration of extrapleural fat planes, invasion of intercostal muscles, rib displacement, and bone destruction 5. In our case, malignant mesothelioma showed unusual growth into neck beyond rib cage and did not show rindlike growth within the hemithorax or rib destruction. MRI permits determination of tumor extent for staging and preoperative evaluation because of its excellent soft tissue contrast resolution. Compared with the SI of adjacent muscle, malignant mesothelioma reveals iso- or slightly high SI on T1-weighted images and moderately high SI on T2- weighted images. With gadolinium-based contrast, this tumor is well enhanced 5. Our case showed same nature with good enhancement, and tumor was well delineated on MR. MR imaging is problem solving method to evaluate questionable area of local tumor extension 5,7. PET in the evaluation of malignant mesothelioma can be useful in the detection of occult distant metastasis and nodal involvement, but the evaluation of local tumor extension is limited due to its poor spatial resolution. Integrated CT-PET imaging provides anatomic and functional information and improves the accuracy of staging. PET standardized uptake value (SUV) is also used in treatment prognosis. Low SUV and epithelial histology mean the best survival and high SUV and nonepithelial histology mean the worst survival 7. This case shows high SUV and epithelial histology, and has been tolerable and still alive for 19 months. Malignant mesothelioma is divided into three histologic categories: epithelial, sarcomatous/fibrous, and biphasic or mixed. About 50% of pleural and 75% of peritoneal mesotheliomas is epithelial type. Mixed type is 30% and sarcomatous type is 15 20% 1. Sarcomatous type has poorer prognosis than epithelial or mixed type 8. Adequate tissue sampling is important to permit accurate diagnosis. Open pleural biopsy, thoracoscopy, and core needle biopsy are recommended to confirm diagnosis but thoracentesis or closed pleural biopsy are not diagnostic in about two thirds of malignant mesothelioma 3,5. In our case, open biopsy was performed. Immunohistochemical stains, especially calretinin and cytokeratin 5/6, are useful to differentiate malignant mesothelioma from adenocarcinoma 3. Radiation therapy or chemotherapy alone showed limited response. Combined chemotherapy using pemetrexed with cisplatin is effective in response rate and median survival time 9. Our case received above mentioned combined chemotherapy and is well responded. Surgery alone showed poor survival time less than 1 year, and multimodality therapy composed of surgery, chemotherapy, and radiation therapy showed longer survival time (18.1 19 months) 5. So accurate staging is important to select surgical candidate, and CT, MR imaging, and PET are crucial in staging. We report an unusual case of malignant mesothelioma appearing as large neck mass with its radiological and pathologic findings contrary to usual rindlike growth along the pleura. References 1. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997;30:403-18. 2. Gill RR, Gerbaudo VH, Jacobson FL, Trotman-Dickenson B, Matsuoka S, Hunsaker A, et al. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am 2008;16:319-39. 3. Barreiro TJ, Katzman PJ. Malignant mesothelioma: a case presentation and review. J Am Osteopath Assoc 2006;106:699-704. 4. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidermiol 1997;145:211-8. 5. Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004;24:105-19. 6. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Ro- 372

Tuberculosis and Respiratory Diseases Vol. 67. No. 4, Oct. 2009 entgenol 1990;155:965-9. 7. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 2006;21:146-53. 8. Beer TW, Buchanan R, Matthews AW, Stradling R, Pullinger N, Pethybridge RJ. Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype. Hum Pathol 1998;29:246-51. 9. Pistolesi M, Rusthoven J. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest 2004;126:1318-29. 373